| Quarterly Results of Gland Pharma (in Rs. Cr.) |
Dec '22 |
Sep '22 |
Jun '22 |
Mar '22 |
Dec '21 |
|
| Net Sales/Income from operations |
925.90 |
1,048.31 |
856.90 |
1,103.01 |
1,063.33 |
|
| Other Operating Income |
-- |
-- |
-- |
-- |
-- |
|
| Total Income From Operations |
925.90 |
1,048.31 |
856.90 |
1,103.01 |
1,063.33 |
|
| EXPENDITURE |
|
|
|
|
|
|
| Consumption of Raw Materials |
433.20 |
504.37 |
340.81 |
602.95 |
464.58 |
|
| Purchase of Traded Goods |
3.90 |
3.79 |
4.75 |
8.81 |
4.72 |
|
| Increase/Decrease in Stocks |
-15.85 |
17.13 |
28.50 |
-66.47 |
34.12 |
|
| Power & Fuel |
-- |
-- |
-- |
25.13 |
-- |
|
| Employees Cost |
100.52 |
101.16 |
98.00 |
94.25 |
81.43 |
|
| depreciat |
37.61 |
36.67 |
34.91 |
31.08 |
27.83 |
|
| Excise Duty |
-- |
-- |
-- |
-- |
-- |
|
| Admin. And Selling Expenses |
-- |
-- |
-- |
-- |
-- |
|
| R & D Expenses |
-- |
-- |
-- |
-- |
-- |
|
| Provisions And Contingencies |
-- |
-- |
-- |
-- |
-- |
|
| Exp. Capitalised |
-- |
-- |
-- |
-- |
-- |
|
| Other Expenses |
120.18 |
126.63 |
114.64 |
89.92 |
129.20 |
|
| P/L Before Other Inc. , Int., Excpt. Items & Tax |
246.35 |
258.56 |
235.29 |
317.36 |
321.43 |
|
| Other Income |
61.51 |
65.62 |
74.39 |
65.23 |
45.67 |
|
| P/L Before Int., Excpt. Items & Tax |
307.86 |
324.19 |
309.68 |
382.59 |
367.10 |
|
| Interest |
2.62 |
1.72 |
0.90 |
2.03 |
1.18 |
|
| P/L Before Exceptional Items & Tax |
305.24 |
322.47 |
308.78 |
380.56 |
365.92 |
|
| Exceptional Items |
-- |
-- |
-- |
-- |
-- |
|
| P/L Before Tax |
305.24 |
322.47 |
308.78 |
380.56 |
365.92 |
|
| Tax |
77.70 |
82.84 |
79.33 |
94.58 |
92.53 |
|
| P/L After Tax from Ordinary Activities |
227.54 |
239.63 |
229.45 |
285.98 |
273.38 |
|
| Prior Year Adjustments |
-- |
-- |
-- |
-- |
-- |
|
| Extra Ordinary Items |
-- |
-- |
-- |
-- |
-- |
|
| Net Profit/(Loss) For the Period |
227.54 |
239.63 |
229.45 |
285.98 |
273.38 |
|
| Equity Share Capital |
16.47 |
16.47 |
16.47 |
16.43 |
16.43 |
|
| Reserves Excluding Revaluation Reserves |
-- |
-- |
-- |
-- |
-- |
|
| Equity Dividend Rate (%) |
-- |
-- |
-- |
-- |
-- |
|
| EPS Before Extra Ordinary |
|
|
|
|
|
|
| Basic EPS |
13.82 |
14.55 |
13.95 |
17.41 |
16.64 |
|
| Diluted EPS |
13.81 |
14.55 |
13.94 |
17.36 |
16.64 |
|
| EPS After Extra Ordinary |
|
|
|
|
|
|
| Basic EPS. |
13.82 |
14.55 |
13.95 |
17.41 |
16.64 |
|
| Diluted EPS. |
13.81 |
14.55 |
13.94 |
17.36 |
16.64 |
|
| Public Share Holding |
|
|
|
|
|
|
| No Of Shares (Crores) |
-- |
-- |
-- |
-- |
-- |
|
| Share Holding (%) |
-- |
-- |
-- |
-- |
-- |
|
| Promoters and Promoter Group Shareholding |
|
|
|
|
|
|
| a) Pledged/Encumbered |
|
|
|
|
|
|
| - Number of shares (Crores) |
-- |
-- |
-- |
-- |
-- |
|
| - Per. of shares (as a % of the total sh. of prom. and promoter group) |
-- |
-- |
-- |
-- |
-- |
|
| - Per. of shares (as a % of the total Share Cap. of the company) |
-- |
-- |
-- |
-- |
-- |
|
| b) Non-encumbered |
|
|
|
|
|
|
| - Number of shares (Crores). |
-- |
-- |
-- |
-- |
-- |
|
| - Per. of shares (as a % of the total sh. of prom. and promoter group). |
-- |
-- |
-- |
-- |
-- |
|
| - Per. of shares (as a % of the total Share Cap. of the company). |
-- |
-- |
-- |
-- |
-- |
|
Source : Dion Global Solutions Limited
